JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Constantinescu, A.
Right arrow Articles by Gordon, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Constantinescu, A.
Right arrow Articles by Gordon, A. S.

J Biol Chem, Vol. 274, Issue 38, 26985-26991, September 17, 1999


Ethanol-induced Translocation of cAMP-dependent Protein Kinase to the Nucleus
MECHANISM AND FUNCTIONAL CONSEQUENCES*

Anastasia ConstantinescuDagger , Ivan DiamondDagger §, and Adrienne S. GordonDagger §parallel

From the Departments of Dagger  Neurology, § Cellular and Molecular Pharmacology, and the  Neuroscience Graduate Program and Center for the Neurobiology of Addiction, Ernest Gallo Clinic and Research Center, University of California, San Francisco, California 94110-3518

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Ethanol induces translocation of the catalytic subunit (Calpha ) of cAMP-dependent protein kinase (PKA) from the Golgi area to the nucleus in NG108-15 cells. Ethanol also induces translocation of the RIIbeta regulatory subunit of PKA to the nucleus; RI and Cbeta are not translocated. Nuclear PKA activity in ethanol-treated cells is no longer regulated by cAMP. Gel filtration and immunoprecipitation analysis confirm that ethanol blocks the reassociation of Calpha with RII but does not induce dissociation of these subunits. Ethanol also reduces inhibition of Calpha by the PKA inhibitor PKI. Pre-incubation of Calpha with ethanol decreases phosphorylation of Leu-Arg-Arg-Ala-Ser-Leu-Gly (Kemptide) and casein but has no effect on the phosphorylation of highly charged molecules such as histone H1 or protamine. cAMP-response element-binding protein (CREB) phosphorylation by Calpha is also increased in ethanol-treated cells. This increase in CREB phosphorylation is inhibited by the PKA antagonist (Rp)-cAMPS and by an adenosine receptor antagonist. These results suggest that ethanol affects a cascade of events allowing for sustained nuclear localization of Calpha and prolonged CREB phosphorylation. These events may account for ethanol-induced changes in cAMP-dependent gene expression.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The cAMP signaling pathway is a major target for ethanol in intact cells (1). Receptor-stimulated increases in intracellular cAMP levels cause dissociation of the catalytic subunit of cAMP-dependent protein kinase (PKA)1 from regulatory subunits; the free catalytic subunit (Calpha ) then phosphorylates intracellular substrates. The duration of the stimulus determines whether these substrates are cytoplasmic or nuclear (2). In the nucleus, PKA Calpha phosphorylates a specific transcription factor, CREB, at serine 133, initiating changes in expression of genes containing cAMP response elements (3-5). Translocation of Calpha to the nucleus following receptor activation is transient, and Calpha rapidly exits the nucleus (6). Export of Calpha out of the nucleus is mediated by binding of Calpha to the heat stable PKA inhibitor, PKI, which contains a nuclear export signal (7, 8).

Brief exposure to ethanol increases basal (9, 10) and receptor-stimulated cAMP production in neuronal cells in culture and isolated brain preparations (9-13). In rat cerebellum, acute ethanol exposure causes an increase in both phosphorylated CREB and cAMP-responsive element binding activity (14). Chronic exposure to ethanol results in an adaptive desensitization of cAMP production, in cells in culture (9, 15-17), lymphocytes isolated from human alcoholics (18), and in mouse brains (19). There is also a decrease in the phosphorylation of CREB in granule cells of rat cerebellum (20). Decreased cAMP production may be because of a decrease in the amount and/or activity of several key proteins in this pathway, including Gsalpha (21), Gq (22), PKA regulatory subunit RI (23), and PKA catalytic activity (24, 25). Increases in Gi have also been reported after chronic exposure to ethanol (26).

Recently, we have shown that one of the catalytic subunits of PKA, Calpha , translocates to the nucleus of NG108-15 cells during prolonged exposure to ethanol; Calpha remains in the nucleus as long as ethanol is present (23). This is in contrast to the rapid exit of Calpha from the nucleus when adenylyl cyclase and PKA are activated by receptors or forskolin (6). Because prolonged intranuclear localization of Calpha during exposure to ethanol could be responsible for ethanol-induced changes in gene expression (see Ref. 1 for review), we undertook a study to determine the mechanism and functional significance of ethanol-induced Calpha translocation. We show here that ethanol-induced nuclear Calpha is functionally active, resulting in the phosphorylation of CREB. This persistent activation appears to be because of, in part, ethanol inhibition of Calpha reassociation with regulatory subunits of PKA and ethanol-dependent inactivation of PKI.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- All chemicals were purchased from Sigma except where indicated.

Cell Culture-- NG108-15 neuroblastoma × glioma hybrid cells obtained from the cell culture facility at the University of California (San Francisco, CA) were grown in 10% Serum Plus (JRH Biosciences, Lenexa, KS) in a 10% CO2 incubator at 37 °C, as described previously (17). The cells were seeded at a density of 2 × 106 cells in T175 flasks for nuclear extract preparations and into 6-well plates at a density of 6 × 104 cells/well for whole cell lysate preparations. For immunocytochemistry experiments, cells were plated on single chamber slides at a density of 4-6 × 104 cells/slide. All cells were maintained for 3 days in complete defined medium (10). On day 3, media were changed, and the cells were maintained in the absence or presence of 200 mM ethanol for 24 h; media were replaced daily. Treatment with 10 µM forskolin was carried out for 30 min. 40 µM (Rp)-cAMPS (Biolog Life Science Institute, La Jolla, CA) and 10 µM BWA1434U (a gift from Glaxo Wellcome) were added 3 h or 30 min, respectively, prior to ethanol or forskolin exposure.

Immunocytochemistry-- Cells were fixed, blocked, and incubated with primary and secondary antibodies as described elsewhere (23). Antibody against CREB phosphorylated at Ser-133 was purchased from NEN BioLabs (Beverly, MA) and diluted 1:200. Secondary antibody (fluorescein isothiocyanate-conjugated goat anti-rabbit) was purchased from Cappel (Costa Mesa, CA) and diluted 1:250.

Nuclear Extracts-- Nuclei were isolated from NG108-15 cells in hypertonic sucrose by the procedure of Laks et al. (27). The nuclear pellet was resuspended in extraction buffer (10 mM Tris-HCl, pH 7.4, 3 mM MgCl2, 2 mM dithiothreitol, 0.5 M NaCl, 0.1 mM EDTA, protease inhibitors (0.1 mM phenylmethylsulfonyl fluoride, 100 µg/ml aprotinin, 100 µg/ml leupeptin), and phosphatase inhibitors (20 mM NaF, 1 mM sodium orthovanadate)) and shaken at 4 °C for 60 min. After centrifugation for 20 min at 67,000 × g, protein content and PKA activity were determined in the supernatant, and a fraction was used for Western blot analysis.

PKA Assay-- Nuclear extracts (0.6 mg/ml protein) were incubated in 50 mM phosphate buffer in the presence and absence of 5 µM cAMP. The reaction was started by adding 10 µl of reaction mixture containing 10 mM magnesium acetate, 200 µM ATP, 200 µM Kemptide, and 12.5 µCi/ml [gamma -32P]ATP, specific activity 3000 Ci/mmol (Amersham Pharmacia Biotech). The reaction was stopped after incubation for 5 min at 37 °C, and the amount of gamma -32P incorporated into Kemptide was determined as described by Rabin et al. (11). The PKA catalytic subunit (Sigma) was reconstituted in 40 mM dithiothreitol to a final concentration of 0.05 mg/ml and was used within 3 days. For each experiment, enzyme was diluted 50-fold in assay buffer with or without various concentrations of ethanol. The final concentration of enzyme was 0.51 units/0.13 mM histone H1 (Life Technologies, Inc.) and 0.2 mM Kemptide, casein, or protamine sulfate.

Gel Filtration Assay-- A Sephadex G-75 column (Amersham Pharmacia Biotech) (15 × 250 mm) was preequilibrated with binding buffer (50 mM potassium phosphate, pH 7.0, 4 mM 2-mercaptoethanol, and 75 mM NaCl) (28) and used to separate PKA holoenzyme from dissociated Calpha and RII subunits. The void volume was determined to be 14 ml. At a flow rate of 1 ml/min, holoenzyme elutes in the void volume (RII at 36 ml and Calpha at 40 ml). Kinase activity was measured in these fractions as described above, using 10 mg/ml protamine sulfate as substrate, because ethanol has no effect on phosphorylation of this substrate (see Fig. 4B). Phosphorylation in the void volume containing holoenzyme is cAMP-dependent, whereas kinase activity in the 40-ml fraction containing Calpha is cAMP-independent.

Immunoprecipitation-- Nuclear extract (0.5 mg of protein) was prepared as described above (except that NaCl was omitted from extraction buffer) and was precleared for 30 min with protein A-conjugated agarose. Supernatant from a 10 min centrifugation at 10,000 rpm was incubated overnight with 2 µg of polyclonal Calpha antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA) and further incubated with protein A-conjugated agarose for 1 h. The immunoprecipitate was centrifuged and washed four times with phosphate-buffered saline, pH 7.0. All incubations were at 4 °C. After a final wash, the immunoprecipitate was resuspended in SDS sample buffer, subjected to SDS-polyacrylamide gel electrophoresis, and probed with RIIbeta (Transduction Laboratories, Lexington, KY) and Calpha antibodies on Western blots.

Western Blots-- Whole cell lysates were prepared by washing cells with ice-cold phosphate-buffered saline and collecting them in SDS buffer (100 µl/well from 4 wells) followed by sonication for 3 s. Cells from 2 remaining wells were used for protein measurements. Nuclear extracts and cell lysates were subjected to SDS-polyacrylamide gel electrophoresis (29), and proteins were transferred to polyvinylidene difluoride membranes. Blots were probed using standard procedures (30) and antibodies against Calpha (a generous gift from Susan Taylor, University of California, San Diego, CA) (diluted 1:10,000), RI, RIIalpha , and RIIbeta (Transduction Laboratories) (1:1000), Cbeta (Santa Cruz Biotechnology Inc.) (1:1000), or total CREB and phosphorylated CREB (NEN BioLabs) (1:1000). Secondary antibodies (NEN BioLabs) were horseradish peroxidase-linked goat anti-rabbit (1:5000) for Calpha , Cbeta , CREB, and phospho-CREB and rabbit anti-mouse (1:1000) for RI and RII. Proteins were detected using LumiGLO chemiluminescence substrate (NEN BioLabs) and exposed to Kodak Biomax film. Scanning densitometry was used to quantitate Western blots using the NIH Image program.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Ethanol Increases the Amount of Calpha and RIIbeta in the Nucleus of NG108-15 Cells-- Using immunocytochemistry, we have shown that chronic ethanol exposure causes translocation of PKA Calpha from the Golgi area into the nucleus in NG108-15 cells (23). To quantitate the extent of Calpha translocation and to determine whether ethanol causes translocation to the nucleus of other PKA subunits in NG108-15 cells, we carried out Western blots on cell lysates and nuclei from these cells. Fig. 1 shows that NG108-15 cells express Calpha , Cbeta , RI, and RIIbeta . Only traces of RIIalpha could be detected in the presence or absence of ethanol (data not shown). After incubation with ethanol for 24 h, there is a 54 ± 2% (mean ± S.E.) increase in the amount of Calpha in the nuclei of ethanol-treated cells and a 40 ± 5% decrease in the amount of RI in whole cell homogenates. These results are in agreement with our previous findings (23) that ethanol causes translocation of Calpha into the nucleus and decreases the amount of RI subunit in whole cells. Fig. 1 also shows that, after exposure to ethanol, nuclear RIIbeta increases by 52 ± 4%. However, there is no RI or Cbeta in the nuclei of either control or ethanol-treated cells.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 1.   Immunodetection of PKA subunits in NG108-15 cells. Western blot of whole cells and nuclei from NG108-15 cells cultured in the presence (+) or absence (-) of 200 mM ethanol for 24 h. Each lane contained 40 or 80 µg of protein. Molecular masses of the PKA subunits are 40 kDa for Calpha and Cbeta , 54 kDa for RIIbeta , and 48 kDa for RI. Data shown are representative of five independent experiments.

Nuclear PKA Activity Is cAMP-independent in Ethanol-treated NG108-15 Cells-- Our data suggest that the amount of Calpha and RIIbeta in the nucleus of NG108-15 cells increases by 50% after chronic exposure to ethanol. To determine whether nuclear Calpha is active or bound to RIIbeta and thus inactive, we measured PKA activity in the presence and absence of cAMP in nuclear extracts. Nuclei were recovered after cell disruption and centrifugation in hypertonic sucrose buffer, and soluble proteins were extracted with 0.5 M NaCl buffer (27). PKA activity in the extract was assayed with Kemptide as substrate (11). Fig. 2 shows that PKA activity remaining in control nuclei after subcellular fractionation is cAMP-dependent, suggesting that Calpha and RIIbeta are associated as a holoenzyme. In contrast, kinase activity in the nuclei of cells treated with 200 mM ethanol for 24 h is cAMP-independent, suggesting that some of the Calpha is no longer associated with RIIbeta . Because total PKA activity did not change in ethanol-treated cells, it is also likely that a significant fraction of nuclear PKA is inactive after ethanol exposure.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 2.   Calpha activity is independent of cAMP in nuclei of NG108-15 cells exposed to ethanol. PKA activity in the nuclear extracts of control and chronic (24 h) ethanol-treated NG108-15 cells in the presence (solid bars) or absence (open bars) of cAMP using Kemptide as substrate. Data shown are the mean ± S.E. for three experiments. *, significantly different (p < 0.03) from the corresponding control cells without cAMP. **, not statistically different from chronically exposed cells minus cAMP (Student's t test)

Ethanol Inhibits Binding of Calpha to RII-- The results in Fig. 2 suggest that active Calpha is not regulated by RII in the presence of ethanol. To test this possibility, we examined RII inhibition of purified Calpha activity in the presence or absence of ethanol. Fig. 3A shows that RII inhibits Calpha catalytic activity by 72 ± 2% in the absence of ethanol. However, preincubation of RII with ethanol strikingly decreases RII inhibition of Calpha . When RII was preincubated with 50 mM ethanol for 2 h, inhibition of Calpha activity by RII was reduced to 25 ± 1%. These results suggest that ethanol inhibits the binding of RII to Calpha , thereby preventing RII inhibition of Calpha activity.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 3.   Ethanol prevents RII reassociation and inhibition of Calpha but does not cause dissociation of these subunits from the holoenzyme. A, inhibition of Calpha activity by RII at various concentrations of ethanol. Regulatory subunits (0.075 ng/µl) were preincubated with 0 (), 25 (black-square), 50 (open circle ), or 100 mM () ethanol for the indicated times, and inhibition of Kemptide phosphorylation by Calpha (0.1 ng/µl) was measured as described under "Experimental Procedures." The concentrations of RII and Calpha were adjusted to equal units of activity. Data are the mean ± S.E. of three experiments. B, effect of cAMP and ethanol on association of Calpha and RII. Equimolar amounts of Calpha and RII (0.3 µM in 200 µl of binding buffer) were incubated for 30 min at room temperature with or without 100 µM cAMP or 50 mM ethanol (RII was preincubated for 60 min with ethanol). The sample applied to a Sephadex G-75 column was eluted with binding buffer containing the indicated additions. PKA activity was assayed in the presence (filled bars) or absence (open bars) of 100 µM cAMP. Results are shown as percent of total activity applied to the column. Data are the mean ± S.E. of three experiments. C, effect of cAMP and ethanol on dissociation of the holoenzyme. Holoenzyme (0.3 µM in 200 µl of buffer) was incubated for 30 min in the presence or absence of 100 µM cAMP or 200 mM ethanol, applied to the column, and eluted with buffer containing the indicated additions. Kinase activity was assayed in the presence (filled bars) or absence (open bars) of 100 µM cAMP and is presented as the percent of total activity applied to the column. Data are the mean ± S.E. of three experiments. D, co-immunoprecipitation of RIIbeta with Calpha in nuclei of NG108-15 cells cultured for 24 h in the presence (+) and absence (-) of 200 mM ethanol. The upper panel shows a representative Western blot of the immunoprecipitate probed with the indicated antibodies. The 55-kDa heavy chain of the polyclonal antibody against Calpha is shown as IgG. The lower panel shows densitometric quantitation of the immunoprecipitated Calpha (open bars) and of the co-immunoprecipitated RIIbeta (filled bars). Data are the mean ± S.E. of four experiments. *, significantly different (p < 0.02) from the corresponding control cells.

To determine directly whether ethanol inhibits binding of RII to Calpha , association of the two subunits was assessed by Sephadex G-75 gel filtration chromatography. The holoenzyme elutes in fraction 14 (void volume) and Calpha in fraction 40. Fig. 3B shows that when equimolar amounts of Calpha and RII are co-incubated for 30 min without cAMP, all kinase activity is cAMP-dependent and is recovered in the void volume (fraction 14). This indicates that RII and Calpha associate to form the holoenzyme. When cAMP is present during both incubation and elution, all PKA activity is recovered in fraction 40 and is cAMP-independent. This indicates that cAMP prevents the association of Calpha and RII. When RII is preincubated with 50 mM ethanol for 60 min before incubation with Calpha and the column eluted with buffer containing 50 mM ethanol, only 46 ± 2% of PKA activity is in the void volume and 44 ± 4% elutes in fraction 40, suggesting that ethanol inhibits the association of RII and Calpha by 54%. This is in agreement with the results in Fig. 3A showing a 45 ± 6% decrease in RII inhibition of Calpha activity after RII was preincubated with 50 mM ethanol for 90 min. Although ethanol inhibits the reassociation of PKA subunits, it has no effect on the dissociation of the holoenzyme. Incubation of holoenzyme with as much as 200 mM ethanol for 30 min did not cause dissociation into subunits, in contrast to dissociation produced by cAMP (Fig. 3C).

Our findings suggest that ethanol interferes with the reassociation of RII and Calpha subunits of PKA in vitro. To determine if ethanol produces the same effect in vivo, we performed co-immunoprecipitation assays in nuclear extracts from NG108-15 cells maintained in the presence and absence of 200 mM ethanol for 24 h. The Calpha ·RIIbeta complex was immunoprecipitated with a polyclonal Calpha antibody and analyzed by Western blot using antibodies against RIIbeta and Calpha . Fig. 3D shows that the amount of RIIbeta co-immunoprecipitated with Calpha is 45 ± 2% less in the nuclei of ethanol-treated cells. This is in agreement with the results in Fig. 3, A and B, and suggests that Calpha and RIIbeta are partially dissociated in the nuclei of these cells.

Ethanol Inhibits Interaction of PKI with Calpha -- We have shown that Calpha remains in the nuclei of ethanol-treated NG108-15 cells as long as ethanol is present and returns to the Golgi 12 h after ethanol is removed (23). Calpha ordinarily exits the nucleus by binding to the heat-stable PKA inhibitor, PKI, which contains a nuclear export signal required for transporting proteins out of the nucleus (7, 8). Because PKI binds to the same hydrophobic site on Calpha as RIIbeta (31), it is possible that ethanol also inhibits the binding of PKI to Calpha . This would be expected to attenuate inhibition of Calpha by PKI and limit the export of Calpha from the nucleus. We used an in vitro kinase assay to test this hypothesis. Under control conditions PKI inhibits purified Calpha -catalyzed phosphorylation by 84 ± 6% (Fig. 4A). Preincubation of PKI with 50 or 100 mM ethanol for 30 min at room temperature decreases PKI inhibition of kinase activity to 31 ± 5% and 14 ± 6%, respectively. Thus, ethanol limits inhibition of PKA by PKI, suggesting that ethanol, similar to its effect on RII, probably inhibits the binding of PKI to Calpha . This would also prevent the exit of Calpha from the nucleus.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 4.   Ethanol prevents PKI inhibition of Calpha activity and differentially affects phosphorylation of substrates. A, ethanol abolishes inhibition of Calpha by PKI. PKI was preincubated in the presence of 50 or 100 mM ethanol for 30 min at room temperature and then added to the reaction mixture (final PKI concentration, 187 ng/µl). Phosphorylation of Kemptide by Calpha at 37 °C was measured at 5 min. Data are the mean ± S.E. of three experiments. *, significantly different (p < 0.01) from the value obtained in the absence of ethanol (Student's t test). B, ethanol preferentially inhibits phosphorylation of specific substrates by Calpha . The catalytic subunit of PKA was preincubated with 50 (open bars) or 100 (hatched bars) mM ethanol for 30 min, and phosphorylation of Kemptide (Kemp), casein (Cas), histone (H1), and protamine sulfate (Prot) was measured. Data are the mean ± S.E. of three experiments.

Ethanol Inhibits Interaction of Calpha with Substrates-- Because PKI and RII share common binding sites on Calpha with substrates (31), we determined the effect of ethanol on Calpha -mediated phosphorylation of different substrates in vitro. Fig. 4B shows that Calpha preincubation with 100 mM ethanol for 30 min inhibits Calpha -dependent phosphorylation of Kemptide or casein by 36%. However, 100 mM ethanol did not inhibit phosphorylation of the highly charged molecules histone H1 or protamine sulfate. Similar results were obtained with 50 mM ethanol. Moreover, preincubation of all substrates with 100 mM ethanol did not affect subsequent phosphorylation, except for casein where inhibition of phosphorylation was reduced from 36 to 25% (data not shown). These results suggest that ethanol inhibits phosphorylation of hydrophobic substrates by interacting primarily with hydrophobic sites on Calpha .

Ethanol-induced Translocation of Calpha Leads to Phosphorylation of CREB-- Calpha localized to the nucleus after exposure to ethanol is active (Fig. 2), suggesting that endogenous nuclear substrates should also be phosphorylated. The transcription factor CREB is a physiological substrate for PKA in the nucleus (3-5). Therefore, we used Western blot analysis and immunocytochemistry with polyclonal antibodies that recognize CREB phosphorylated at serine 133 (phospho-CREB) to determine whether ethanol increases CREB phosphorylation. Fig. 5, A and B, shows that ethanol induces phosphorylation of CREB (p-CREB) reaching a maximum at 3 h of exposure. Most importantly phospho-CREB remains higher than control levels from 1-24 h of ethanol treatment; there was no change in the amount of CREB (Fig. 5A). Because CREB can be phosphorylated at serine 133 by several other kinases (32-37), we used the PKA antagonist (Rp)-cAMPS to confirm that the ethanol-induced increase in phospho-CREB was due primarily to PKA. Fig. 6 shows an immunocytochemical image of phospho-CREB in NG108-15 cells before and after treatment with either forskolin or ethanol. The amount of phospho-CREB in the nucleus after a 3-h exposure to ethanol is similar to that obtained by treating the cells with forskolin for 30 min (Fig. 6). Forskolin- and ethanol-induced phosphorylation of CREB was greatly reduced by preincubating cells with (Rp)-cAMPS, suggesting that PKA is responsible for CREB phosphorylation induced by ethanol.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 5.   CREB phosphorylation induced by ethanol in NG108-15 cells. A, phosphorylated CREB and total CREB protein in homogenates of NG108-15 cells as a function of time of ethanol exposure. Western blot of NG108-15 cells cultured in the presence or absence of 200 mM ethanol for the indicated times. C represents control cells incubated for 24 h in the absence of ethanol, and F represents cells treated with 10 µM forskolin for 30 min. Data shown are representative of four experiments. B, densitometric quantitation of phosphorylation of CREB in NG108-15 cells treated with ethanol. Data are the means of four experiments. *, significantly different (p < 0.05) from the corresponding control cells without ethanol (Student's t test).


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 6.   Ethanol-induced CREB phosphorylation in NG108-15 cells is blocked by adenosine receptor and PKA antagonists. Immunocytochemical detection of phospho-CREB in NG108-15 cells treated with ethanol for 3 h. Positive control: cells treated for 30 min with 10 µM forskolin. Pretreatment with (Rp)-cAMPS and BWA1434U was as described under "Experimental Procedures." All images are ×400 magnification obtained with a Bio-Rad 1024 confocal microscope. Data shown are representative of three experiments.

Adenosine A2 Receptors Mediate Ethanol-induced CREB Phosphorylation-- We have previously shown that adenosine A2 receptors mediate acute ethanol-induced increases in cAMP levels; adenosine A2 receptor blockade completely prevents ethanol-induced cAMP accumulation (9, 10). If adenosine receptor-dependent increases in cAMP levels are responsible for ethanol-induced activation and translocation of Calpha to the nucleus, an adenosine receptor antagonist should also block phosphorylation of CREB. BWA1434U, an adenosine receptor antagonist, blocked ethanol-induced CREB phosphorylation but, as expected, had no effect on forskolin-induced CREB phosphorylation, which bypasses receptor stimulation (Fig. 6).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Immunocytochemical studies in our laboratory have shown that chronic exposure of NG108-15 cells to ethanol caused a dramatic and specific translocation of Calpha from the Golgi area to the nucleus (23). This translocation is confirmed by Western blot analysis of homogenates and nuclei of control and ethanol-treated cells (Fig. 1). We demonstrate here that the RIIbeta regulatory subunit is also translocated to the nucleus following chronic ethanol exposure, but ethanol does not alter localization of the Cbeta catalytic subunit. Nuclei of control NG108-15 cells contain both Calpha and RIIbeta , probably associated as holoenzyme, because cAMP is required for PKA activation (Fig. 2). After chronic ethanol exposure, however, there is a substantial increase in the amounts of both Calpha and RIIbeta in the nucleus (Fig. 1). Once in the nuclei of ethanol-treated cells, some Calpha and RIIbeta appear to be dissociated because PKA activity is cAMP-independent (Fig. 2). This is likely because of the inhibition of the association of Calpha and RII by ethanol (Fig. 3B) thereby blocking RII regulation of Calpha activity (Fig. 3A). Thus, a 90-min incubation with 50 mM ethanol prevents the association of RII and Calpha by 50% (Fig. 3B) and decreases RII inhibition of Calpha activity by 45% (Fig. 3A). This concentration of ethanol is clinically relevant, particularly in chronic alcoholics (38). Moreover, ethanol inhibition of Calpha ·RIIbeta holoenzyme formation in vitro is reproduced in vivo because 45% of nuclear RIIbeta fails to co-immunoprecipitate with Calpha after 24 h of ethanol treatment (Fig. 3D).

Our data also suggest a mechanism for the prolonged sequestration of functionally active Calpha in the nucleus in the presence of ethanol. Neurotransmitter- and hormone-dependent signal transduction via cAMP cause a transient translocation of PKA Calpha from the cytoplasm to the nucleus with brief activation of transcription; Calpha returns rapidly to the cytoplasm after binding to PKI (6-8). During prolonged exposure to ethanol, however, Calpha remains in the nucleus and returns to the Golgi only 6-12 h after ethanol is removed (23). This unusual time course for Calpha translocation could be because of the interaction of ethanol with hydrophobic binding sites on PKI that prevents PKI from binding to Calpha , thereby inhibiting PKI-mediated export of Calpha out of the nucleus. Indeed, the data presented here show that PKI inhibition of Calpha activity is greatly reduced after preincubation with ethanol (Fig. 4A). Presumably this is because ethanol prevents the binding of PKI to Calpha , similar to ethanol interfering with the association of RIIbeta with Calpha (Fig. 3, B and D). Ethanol also appears to limit access of specific substrates to Calpha ; phosphorylation of Kemptide and casein by Calpha is reduced after preincubation of Calpha with ethanol, whereas phosphorylation of histone and protamine are unaffected by ethanol (Fig. 4B). The binding of substrates and RII and PKI to the catalytic subunit of PKA involves two hydrophobic interactions and three electrostatic contacts (31). Recent evidence suggests that ethanol can bind directly to hydrophobic pockets in proteins (39-41). Therefore, we propose that ethanol-induced sustained translocation of Calpha to the nucleus is related to ethanol inhibition of the reassociation of Calpha with RII and/or the binding of Calpha to PKI. This may be because of ethanol-induced conformational changes at hydrophobic sites near the binding domains. This explanation is also consistent with our observation that ethanol does not inhibit phosphorylation of substrates that are highly charged, such as histone H1 and protamine sulfate (Fig. 4B), where hydrophilic binding to Calpha probably predominates. Preincubation of substrates with ethanol does not produce the same decrease in Kemptide and casein phosphorylation as preincubation of Calpha . We presume this occurs because Kemptide and casein have a random coil secondary structure (42, 43) that is less affected by ethanol.

Two apparent methodological discrepancies in our studies are informative. First, in our previous paper (23), ethanol caused the translocation to the nucleus of almost all Calpha observable by confocal microscopy. In this report, Western blot analysis indicates that only approximately 50% of Calpha is translocated to the nucleus. This discrepancy can be explained by methodological differences; we used confocal microscopy in our earlier report and Western blot analysis in this study. Confocal microscopy results in visualization of densely localized Calpha , as seen in the Golgi and nuclei. Diffusely distributed Calpha , on the other hand, is more difficult to observe by microscopy but is readily detected by Western blot analysis. The second discrepancy is that Western blot analysis shows a 50% increase in Calpha in the nucleus after exposure to ethanol; this is not accompanied by an increase in PKA enzymatic activity, suggesting that some nuclear Calpha may be rendered inactive and no longer regulated by cAMP after chronic exposure to ethanol. This raises the very interesting possibility that some Calpha may be retained in the nucleus after chronic exposure to ethanol by binding to a putative inactivating protein distinct from PKI and RII. The existence of such a hypothetical Calpha -binding protein in the nucleus is suggested by our observation that sustained nuclear localization of Calpha in the presence of ethanol requires protein synthesis.2 Studies are underway to identify this putative binding protein.

Ethanol-induced translocation of Calpha to the nucleus should enhance cAMP-dependent gene expression and reduce phosphorylation of membrane or cytoplasmic proteins. Because Calpha is active for long periods of time, there may even be inappropriate transcription of cAMP-responsive genes. This is suggested by our finding that ethanol causes a striking increase in CREB phosphorylation with a peak at 3 h, followed by a sustained increase in phospho-CREB even after 24 h of ethanol exposure (Fig. 5). The peak of CREB phosphorylation at 3 h appears to be because of unrestrained Calpha activity, apparently because ethanol inhibits RII and PKI binding to Calpha (Figs. 3 and 4A). After 3 h, phospho-CREB remains higher than in control cells but decreases despite the continued presence of Calpha in the nucleus (see Ref. 18 and Fig. 4). This may be related to the observation that CREB phosphorylation following activation of the cAMP pathway is also regulated by protein phosphatases such as protein phosphatase 2B in neurons of the striatum (44) and protein phosphatase 1 in PC12 cells (45). Therefore, the decrease in CREB phosphorylation after 3 h may be because of an ethanol-induced increase in nuclear protein phosphatase activity.

Several reports have shown that other kinases can phosphorylate CREB in vitro and in vivo on Ser-133, e.g. calmodulin-dependent kinase IV (32-35), mitogen-activated protein kinase (36), and protein kinase C (37). In NG108-15 cells, the increase in CREB phosphorylation during ethanol exposure appears to be due primarily to Calpha , because the PKA-specific inhibitor (Rp)-cAMPS, which acts directly on the holoenzyme to prevent its dissociation, significantly but not completely inhibits phosphorylation of CREB (Fig. 6). This suggests the possibility that an early activation of PKA by ethanol-induced increases in cAMP may also up-regulate other kinases that phosphorylate CREB. However, an ethanol-induced increase in cAMP production must be required for CREB phosphorylation in the nucleus because BWA1434U, an adenosine receptor antagonist that blocks acute ethanol-induced increases in cAMP levels (9, 10), completely abolishes ethanol-induced phosphorylation of CREB (Fig. 6). This is consistent with recent data in our laboratory showing that both (Rp)-cAMPS and BWA1434U prevent acute ethanol-induced translocation of Calpha into the nucleus.2 Moreover, a requirement for cAMP is also supported by data in Fig. 3C showing that ethanol alone does not dissociate the PKA holoenzyme.

In summary, the major finding in this paper is that ethanol-induced translocation of PKA Calpha to the nucleus in NG108-15 cells causes a sustained increase in CREB phosphorylation. CREB phosphorylation has long been implicated in the regulation of many cellular functions and in short and long term learning and memory (46-48). Taken together with recent genetic data implicating cAMP signaling in alcohol-related behaviors (49, 50), ethanol regulation of cAMP-dependent gene transcription may play an important role in molecular mechanisms that underlie alcoholism and addictive behaviors.

    ACKNOWLEDGEMENTS

We thank Drs. Michael Miles and Dorit Ron for helpful discussion and critical review of the manuscript.

    FOOTNOTES

* This work was supported in part by National Institutes of Health Grants R01 AA10039 and R01 AA10030.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

parallel To whom correspondence should be addressed: Bldg. 1, Rm. 101, Ernest Gallo Clinic and Research Center, 1001 Potrero Ave., San Francisco, CA 94110-3518. Tel.: (415) 648-7111 (ext. 305); Fax: (415) 648-7116; E-mail: adrienn@itsa.ucsf.edu.

2 D. Dohrman, H.-m., Chen, I. Diamond, and A. Gordon, manuscript in preparation.

    ABBREVIATIONS

The abbreviations used are: PKA, cAMP-dependent protein kinase; CREB, cAMP-response element-binding protein; PKI, protein kinase inhibitor, cAMPS, adenosine 3',5' cyclic monophosphorothioate.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Diamond, I., and Gordon, A. S. (1997) Physiol. Rev. 77, 1-20[Abstract/Free Full Text]
2. Bailey, C. H., Bartsch, D., and Kandel, E. R. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 13445-13452[Abstract/Free Full Text]
3. Bailey, C. H., Alberini, C., Ghirardi, M., and Kandel, E. R. (1994) Adv. Second Messenger Phosphoprotein Res. 29, 529-544[Medline] [Order article via Infotrieve]
4. Brindle, P., Nakajima, T., and Montminy, M. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 10521-10525[Abstract/Free Full Text]
5. Hagiwara, M., Brindle, P., Harootunian, A., Armstrong, R., Rivier, J., Vale, W., Tsien, R., and Montminy, M. R. (1993) Mol. Cell. Biol. 13, 4852-4859[Abstract/Free Full Text]
6. Nigg, E. A., Hilz, H., Eppenberger, H. M., and Dutly, F. (1985) EMBO J. 4, 2801-2806[Medline] [Order article via Infotrieve]
7. Meinkoth, J. L., Alberts, A. S., Went, W., Fantozzi, D., Taylor, S. S., Hagiwara, M., Montminy, M., and Feramisco, J. R. (1993) Mol. Cell. Biochem. 127, 179-186
8. Fantozzi, D. A., Harootunian, A. T., Wen, W., Taylor, S. S., Feramisco, J. R., Tsien, R. Y., and Meinkoth, J. L. (1994) J. Biol. Chem. 269, 2676-2686[Abstract/Free Full Text]
9. Nagy, L. E., Diamond, I., Collier, K., Lopez, L., Ullman, B., and Gordon, A. S. (1989) Mol. Pharmacol. 36, 744-748[Abstract]
10. Sapru, M. K., Diamond, I., and Gordon, A. S. (1994) J. Pharmacol. Exp. Ther. 271, 542-548[Abstract/Free Full Text]
11. Rabin, R. A., Edelman, A. M., and Wagner, J. A. (1992) J. Pharmacol. Exp. Ther. 262, 257-262[Abstract/Free Full Text]
12. Tabakoff, B., Hoffman, P. L., Lee, J. M., Saito, T., Willard, B., and De Leon-Jones, F. (1988) N. Engl. J. Med. 318, 134-139[Abstract]
13. Saito, T., Lee, J. M., and Tabakoff, B. (1985) J. Neurochem. 44, 1037-1044[CrossRef][Medline] [Order article via Infotrieve]
14. Yang, X., Diehl, A. M., and Wand, G. S. (1996) J. Pharmacol. Exp. Ther. 278, 338-346[Abstract/Free Full Text]
15. Rabe, C. S., Giri, P. R., Hoffman, P. L., and Tabakoff, B. (1990) Biochem. Pharmacol. 40, 565-571[CrossRef][Medline] [Order article via Infotrieve]
16. Rabin, R. A., Fiorella, D., and Van Wylen, D. G. (1993) J. Neurochem. 60, 1012-1017[CrossRef][Medline] [Order article via Infotrieve]
17. Gordon, A. S., Collier, K., and Diamond, I. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 2105-2108[Abstract/Free Full Text]
18. Diamond, I., Wrubel, B., Estrin, W., and Gordon, A. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 1413-1416[Abstract/Free Full Text]
19. Wand, G. S., Diehl, A. M., Levine, M. A., Wolfgang, D., and Samy, S. (1993) J. Biol. Chem. 268, 2595-2601[Abstract/Free Full Text]
20. Yang, X., Horn, K., Baraban, J. M., and Wand, G. S. (1998) J. Neurochem. 70, 224-232[Medline] [Order article via Infotrieve]
21. Mochly-Rosen, D., Chang, F. H., Cheever, L., Kim, M., Diamond, I., and Gordon, A. S. (1988) Nature 333, 848-850[CrossRef][Medline] [Order article via Infotrieve]
22. Williams, R. J., and Kelly, E. (1993) J. Neurochem. 61, 1163-1166[CrossRef][Medline] [Order article via Infotrieve]
23. Dohrman, D. P., Diamond, I., and Gordon, A. S. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 10217-10221[Abstract/Free Full Text]
24. Coe, I. R., Dohrman, D. P., Constantinescu, A., Diamond, I., and Gordon, A. S. (1996) J. Pharmacol. Exp. Ther. 276, 365-369[Abstract/Free Full Text]
25. Rius, R. A., Govoni, S., Battaini, F., and Trabucchi, M. (1986) Brain Res. 365, 355-359[CrossRef][Medline] [Order article via Infotrieve]
26. Charness, M. E., Querimit, L. A., and Henteleff, M. (1988) Biochem. Biophys. Res. Commun. 155, 138-143[CrossRef][Medline] [Order article via Infotrieve]
27. Laks, M. S., Harrison, J. J., Schwoch, G., and Jungmann, R. A. (1981) J. Biol. Chem. 256, 8775-8785[Abstract/Free Full Text]
28. Rangel-Aldao, R., and Rosen, O. M. (1976) J. Biol. Chem. 251, 3375-3380[Abstract/Free Full Text]
29. Laemmli, U. K. (1970) Nature 227, 680-685[CrossRef][Medline] [Order article via Infotrieve]
30. Towbin, H., Staehelin, T., and Gordon, J. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 4350-4354[Abstract/Free Full Text]
31. Kemp, B. E., Faux, M. C., Means, A. R., House, C., Tiganis, T., Hu, S.-H., and Mitchelhill, K. I. (1994) in Protein Kinases (Woodgett, J. R., ed) , pp. 30-67, IRL Press at Oxford University Press, New York
32. Hanson, P. I., and Schulman, H. (1992) Annu. Rev. Biochem. 61, 559-601[CrossRef][Medline] [Order article via Infotrieve]
33. Greenberg, M. E., Thompson, M. A., and Sheng, M. (1992) J. Physiol. (Paris) 86, 99-108[CrossRef][Medline] [Order article via Infotrieve]
34. Sun, P., Lou, L., and Maurer, R. A. (1996) J. Biol. Chem. 271, 3066-3073[Abstract/Free Full Text]
35. Bito, H., Deisseroth, K., and Tsien, R. W. (1996) Cell 87, 1203-1214[CrossRef][Medline] [Order article via Infotrieve]
36. Bailey, C. H., Kaang, B. K., Chen, M., Martin, K. C., Lim, C. S., Casadio, A., and Kandel, E. R. (1997) Neuron 18, 913-924[CrossRef][Medline] [Order article via Infotrieve]
37. Xie, H., and Rothstein, T. L. (1995) J. Immunol. 154, 1717-1723[Abstract]
38. Diamond, I., and Messing, R. O. (1994) West. J. Med. 161, 279-287[Medline] [Order article via Infotrieve]
39. Slater, S. J., Cox, K. J., Lombardi, J. V., Ho, C., Kelly, M. B., Rubin, E., and Stubbs, C. D. (1993) Nature 364, 82-84[CrossRef][Medline] [Order article via Infotrieve]
40. Li, C., Peoples, R. W., and Weight, F. F. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 8200-8204[Abstract/Free Full Text]
41. Eckenhoff, R. G., and Shuman, H. (1993) Anesthesiology 79, 96-106[Medline] [Order article via Infotrieve]
42. Rosevear, P. R., Fry, D. C., Mildvan, A. S., Doughty, M., O'Brian, C., and Kaiser, E. T. (1984) Biochemistry 23, 3161-3173[CrossRef][Medline] [Order article via Infotrieve]
43. de Jongh, H. H., Goormaghtigh, E., and Ruysschaert, J. M. (1997) Biochemistry 36, 13603-13610[CrossRef][Medline] [Order article via Infotrieve]
44. Liu, F. C., and Graybiel, A. M. (1996) Neuron 17, 1133-1144[CrossRef][Medline] [Order article via Infotrieve]
45. Hagiwara, M., Alberts, A., Brindle, P., Meinkoth, J., Feramisco, J., Deng, T., Karin, M., Shenolikar, S., and Montminy, M. (1992) Cell 70, 105-113[CrossRef][Medline] [Order article via Infotrieve]
46. Martin, K. C., Casadio, A., Zhu, H., E. Y., Rose, J. C., Chen, M., Bailey, C. H., and Kandel, E. R. (1997) Cell 91, 927-938[CrossRef][Medline] [Order article via Infotrieve]
47. Bartsch, D., Ghirardi, M., Skehel, P. A., Karl, K. A., Herder, S. P., Chen, M., Bailey, C. H., and Kandel, E. R. (1995) Cell 83, 979-992[CrossRef][Medline] [Order article via Infotrieve]
48. Kaang, B. K., Kandel, E. R., and Grant, S. G. (1993) Neuron 10, 427-435[CrossRef][Medline] [Order article via Infotrieve]
49. Moore, M. S., DeZazzo, J., Luk, A. Y., Tully, T., Singh, C. M., and Heberlein, U. (1998) Cell 93, 997-1007[CrossRef][Medline] [Order article via Infotrieve]
50. Thiele, T. E., Marsh, D. J., Ste, Marie, L., Bernstein, I. L., and Palmiter, R. D. (1998) Nature 396, 366-369[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
Cancer Res.Home page
E. Meoli, I. Bossis, L. Cazabat, M. Mavrakis, A. Horvath, S. Stergiopoulos, M. L. Shiferaw, G. Fumey, K. Perlemoine, M. Muchow, et al.
Protein Kinase A Effects of an Expressed PRKAR1A Mutation Associated with Aggressive Tumors
Cancer Res., May 1, 2008; 68(9): 3133 - 3141.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
D. Ron and R. Jurd
The "Ups and Downs" of Signaling Cascades in Addiction
Sci. Signal., November 8, 2005; 2005(309): re14 - re14.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
C. R. Goodlett, K. H. Horn, and F. C. Zhou
Alcohol Teratogenesis: Mechanisms of Damage and Strategies for Intervention
Experimental Biology and Medicine, June 1, 2005; 230(6): 394 - 406.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. W. Maas Jr, S. K. Vogt, G. C. K. Chan, V. V. Pineda, D. R. Storm, and L. J. Muglia
Calcium-Stimulated Adenylyl Cyclases Are Critical Modulators of Neuronal Ethanol Sensitivity
J. Neurosci., April 20, 2005; 25(16): 4118 - 4126.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
A. E. Medina, T. E. Krahe, and A. S. Ramoa
Early Alcohol Exposure Induces Persistent Alteration of Cortical Columnar Organization and Reduced Orientation Selectivity in the Visual Cortex
J Neurophysiol, March 1, 2005; 93(3): 1317 - 1325.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Constantinescu, M. Wu, O. Asher, and I. Diamond
cAMP-dependent Protein Kinase Type I Regulates Ethanol-induced cAMP Response Element-mediated Gene Expression via Activation of CREB-binding Protein and Inhibition of MAPK
J. Biol. Chem., October 8, 2004; 279(41): 43321 - 43329.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. R. Elliott, R. A. Shanks, I. U. Khan, J. W. Brooks, P. J. Burkett, B. J. Nelson, V. Kyttaris, Y.-T. Juang, G. C. Tsokos, and G. M. Kammer
Down-Regulation of IL-2 Production in T Lymphocytes by Phosphorylated Protein Kinase A-RII{beta}
J. Immunol., June 15, 2004; 172(12): 7804 - 7812.
[Abstract] [Full Text] [PDF]